On the heels of the FTC’s opposition to Lockheed Martin’s acquisition of Aerojet Rocketdyne and Lockheed’s termination of the deal, the Department of Defense (DoD) released a report expressing concerns about the state of competition among its contractors. Of particular note, the report encourages DoD action to (1) increase oversight of M&A transactions and (2)
Biden Administration 100-Day Supply Chain Assessment: Insights for Pharmaceutical Manufacturers
U.S. Senators Propose Trade-Pact Waivers Amidst Focus on Domestic Preference Laws
President Trump Issues Executive Order Prohibiting “Divisive Concepts” in Federal Contractor Trainings
Trump Administration Increases Uncertainty for Pharmaceutical Manufacturing
Look Before You Release — ASBCA Enforces Release of Claims to Contractor’s Detriment
The decision, Appeal of Horton Construction Co., Inc., ASBCA No. 61085 (June 2, 2020), concerned
FEMA Continues to Push Defense Production Act Authority On Several Fronts
On May 12th, FEMA announced that it plans to invoke DPA authority which permits the President to consult with representatives of industry, business, financing,
A Coronavirus Contractor’s Guide to the PREP Act
We’ve covered several topics already this week on the U.S. Government’s varied responses to the COVID-19 outbreak and how these responses will affect contractors that do business with the government, including BARDA’s EZ-BAA for COVID-19 diagnostics, mission-essential services during the outbreak, and how excusable delay provisions may help federal contractors affected by the
Suspension & Debarment Update: SBA to Sharpen Suspension & Debarment Procedures